Desjardins initiated coverage of Extendicare (EXETF) with a Buy rating and C$34.50 price target The firm believes that Extendicare’s shift toward seniors care services, combined with an aging Canadian population, has “significantly enhanced the company’s growth profile.” Desjardins forecasts double-digit earnings CAGRs for EBITDA, EPS and FFO, and sees “further upside in the stock” despite its significant price appreciation over the last two years.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EXETF:
- Extendicare Declares April 2026 Monthly Dividend for Shareholders
- Extendicare Raises $450 Million in Debut Investment-Grade Note Offering
- Extendicare launches $450 million inaugural investment-grade notes to strengthen balance sheet
- Extendicare Sets Date for Q1 2026 Results and Investor Call
- Extendicare upgraded to Buy from Hold at TD Securities
